Found 3 results
Name | Type of Offering | Accepted Date |
---|---|---|
Imbria Pharmaceuticals, Inc.
|
D | 2025-04-01 15:56:37 |
Amount To Be Raised
$124,195,815
Associated Brokers / Dealers
N/A
CIK Number
0001745672
Filed Document
0001745672-25-000003
Exclusions or Exemptions
506b
Accepted Date
2025-04-01 15:56:37
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Imbria Pharmaceuticals, Inc.
|
D | 2018-07-06 20:02:13 |
Amount To Be Raised
$40,249,995
Associated Brokers / Dealers
N/A
CIK Number
0001745672
Filed Document
0001745672-18-000001
Exclusions or Exemptions
506b
Accepted Date
2018-07-06 20:02:13
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Imbria Pharmaceuticals, Inc.
|
D | 2020-07-02 14:28:49 |
Amount To Be Raised
$80,734,932
Associated Brokers / Dealers
N/A
CIK Number
0001745672
Filed Document
0001713695-20-000004
Exclusions or Exemptions
506b
Accepted Date
2020-07-02 14:28:49
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
MASSACHUSETTS
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|